Since identifying the cybersecurity incident on August 25, Boston Scientific has worked closely with CrowdStrike and other third-party cybersecurity experts to contain the threat, conduct a ...

Chronic pain is often misunderstood, underdiagnosed and undertreated. Today, new treatment options are helping more people find relief.

To supplement our unaudited consolidated financial statements presented on a GAAP basis, we disclose certain non-GAAP financial measures, including adjusted net income (loss), adjusted net income ...

"Our team delivered a solid quarter while continuing to navigate a dynamic environment," says Mike Mahoney, chairman and chief executive officer, Boston Scientific. "We are focused on disciplined ...

MARLBOROUGH, Mass., May 18, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has invested $1.5 billion in return for an approximately 34% equity stake in MiRus LLC, a ...

MARLBOROUGH, Mass., May 18, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into an accelerated share repurchase (ASR) agreement with JPMorgan Chase ...

Positive data for FARAPULSE™ Pulsed Field Ablation and WATCHMAN™ LAAC Devices underscore therapy safety and effectiveness in late-breaking clinical trial sessions The randomized AVANT GUARD clinical ...

MARLBOROUGH, Mass., April 22, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.203 billion during the first quarter of 2026, growing 11.6 percent on a reported ...

Amounts may not add due to rounding. Growth rates are based on actual, non-rounded amounts and may not recalculate precisely. Net sales growth rates that exclude the impact of foreign currency ...

MARLBOROUGH, Mass. and NEW ORLEANS, March 28, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the CHAMPION-AF global clinical trial met all primary and secondary ...

"Penumbra is a well-established company with an experienced, high-performing team and this acquisition offers Boston Scientific an opportunity to enter new, fast-growing segments within the vascular ...

The eCoin system, approved by the U.S. Food and Drug Administration in 2022, is a coin-sized device that is placed under the skin, near the ankle, during a minimally invasive procedure. The device is ...